Detalhe da pesquisa
1.
A novel non-opioid protocol for medically supervised opioid withdrawal and transition to antagonist treatment.
Am J Drug Alcohol Abuse
; 44(3): 302-309, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-28795846
2.
Plasminogen mediates the atherogenic effects of macrophage-expressed urokinase and accelerates atherosclerosis in apoE-knockout mice.
Proc Natl Acad Sci U S A
; 105(44): 17109-14, 2008 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-18957535
3.
Does Maternal Buprenorphine Dose Affect Severity or Incidence of Neonatal Abstinence Syndrome?
J Addict Med
; 12(6): 435-441, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29905586
4.
Urokinase plasminogen activator induces pro-fibrotic/m2 phenotype in murine cardiac macrophages.
PLoS One
; 8(3): e57837, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23536772
5.
Mechanisms of cardiac fibrosis induced by urokinase plasminogen activator.
J Biol Chem
; 281(22): 15345-51, 2006 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-16554301